AMD Shares Slide as HSBC Downgrades Stock Over Nvidia Concerns; Absci Collaboration Announced
Following HSBC downgrading of the semiconductor company's stock, Advanced Micro Devices ( AMD, Financials) shares fell over 5 ...
AbSci’s Strategic Growth Bolstered by AMD Collaboration and Promising Pipeline Advancements
Analyst Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on AbSci (ABSI – Research Report) and keeping the price target at ...
AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal
Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
AMD战略携手Absci，2000万美元加码AI新药研发
近日，专注于生成式人工智能新药研发的Absci Corporation宣布了一项与AMD的战略合作计划，旨在通过部署AMD Instinct加速器和ROCm软件，为Absci的关键新药研发工作负载提供强大支持，特别是其创新的从头抗体设计模型。
Absci price target lowered to $5 from $6 at KeyBanc
KeyBanc lowered the firm’s price target on Absci (ABSI) to $5 from $6 and keeps an Overweight rating on the shares. The firm notes healthcare ...
Absci rises after report on $20M investment by Advanced Micro Devices
Absci (NASDAQ:ABSI) was rising after a media report about the semiconductor company Advanced Micro Devices (NASDAQ:AMD) ...
AMD投资2000万美元于Absci以扩大人工智能芯片在医疗保健板块的销售 - 华尔街日报
Investing.com -- 据华尔街日报报道，美国超微公司AMD计划向华盛顿州的药物发现公司Absci投资2000万美元，旨在增加其人工智能 (AI)芯片在医疗保健板块的使用。
Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery
Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to unlock complex targets for drug discovery, development, and diagnostics ...